IMV’s CEO, Frederic Ors, was interviewed by CTV Montreal, providing more details about the IMV’s COVID-19 vaccine candidate and unique delivery platform, DPX.
- Novagevity to Develop Canada’s First Plant-Based Meal Replacement Beverage, Receives $300k from ACOA
- IMV CEO interviewed by CTV: Canadian lab races for COVID-19 vaccine
- IMV featured on CTV: NS lab gets green light to test COVID-19 vaccine on humans
- Sona Stock Up 123% on Test Results
- Adaptiiv Wins $100K Health Challenge